OVERVIEW

Clinical Implications for the Latest Real-World Evidence in Novel Low-Grade UTUC Therapies is organized by Prime Education, LLC and will be held from Aug 30, 2024 - Aug 29, 2025.

Release Date: August 30, 2024
Expiration Date: August 29, 2025

Description:
This on-demand video provides a comprehensive guide to tailoring treatment plans for upper tract urothelial carcinoma (UTUC) using the latest treatment strategies. It explores leveraging new clinical evidence and real-world data to make informed treatment decisions, particularly focusing on patient selection and monitoring and mitigating adverse events from chemoablative therapies. The expert-led video also introduces a downloadable UTUC FAQ resource for continued learning and reference.

Learning Objectives:

  • Evaluate new and emerging real-world and clinical trial data on novel therapies for low-grade (LG) upper tract urothelial carcinoma (UTUC) across a variety of patient types
  • Design guideline-adherent, individualized treatment plans for patients with UTUC, including strategies for adverse event management

Additional details will be posted as soon as information is available.

 

Credits

Accreditation: 
 Joint Accreditation Statement
In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Credit Designation Statement
PRIME® designates this Enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Physician Assistant Accreditation Statement
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioner Accreditation Statement
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 0.5 contact hour (which includes 0.38 hour of pharmacology).
Pharmacist Accreditation Statement
This Knowledge-based activity has been approved for 0.5 contact hour (0 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-24-203-H01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service (help@nabp.pharmacy).
Nurse Accreditation Statement
PRIME® designates this activity for 0.5 contact hour.

  • 0.5 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • 0.5 CME
  • TARGET AUDIENCE

    NursingPharmacistOncologistsUrologistsNursesNurse PractitionersMedical Oncologists

    SPECIALITIES

    UrologyOncology

    RELATED ONLINE COURSES

    3 Hours
    ...
    More actions

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910
    By MasterHealthPro (MHP)

    Webcast

    Psychiatry
    72 CPD Hours
    More actions
    IN₹32,499